fbpx

TRANSCRIPT: PSA National President opening address at PSA24

2 August 2024

 

Thank you, Aunty Joan Bell, for the beautiful and warm Welcome to Country and for sharing her story with us.

 

I too, would like to acknowledge the traditional custodians of the land we meet on today, the Gadigal People of the Eora Nation.

 

In the spirit of reconciliation, PSA acknowledges the Traditional Custodians of Country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present. I personally extend that respect to all Aboriginal and Torres Strait Islander peoples today.

 

Good morning PSA.

 

In preparing today’s opening, I reflected on our journey in the past 2 years.

 

Two years ago, I delivered my first opening plenary at PSA22– I was exhilarated, nervous, but motivated.

 

This time last year, as I delivered my second opening plenary – I, together with the profession that I love dearly, we were solemn. I would say melancholy at times, but we were cautiously hopeful. We were hopeful because of our belief in our profession, in our community we serve, in our resilience, in our impact and our irreplaceable role.

 

Today 12 months later, I stand here, together with you PSA members, my Board, Branch Presidents, Branch Committees and the amazing PSA Team, and the 3 words I’ve chosen are optimistic, assured, and focused.

 

On behalf of our profession, I am grateful to our government. I want to acknowledge and thank our Federal Minister for Health and Aged Care Minister Mark Butler who will be joining us this afternoon, and Assistant Minister Emma McBride, who is present with us today.

 

After 15 months of uncertainty, our profession welcomed the signing of the 8th Community Pharmacy Agreement and Strategic Agreement. I want to acknowledge the work of the Pharmacy Guild of Australia, their National President Prof Trent Twomey and his team, some of them are with us today. The 8CPA has delivered the much-needed certainty our community pharmacy sector needed.

 

Also on behalf of the profession, I am incredible proud of PSA’s achievement and signing of the first, historic, Strategic Agreement on Pharmacist Professional Practice is monumental.

 

For the first time, the Strategic Agreement articulates the Australian Government’s commitment to support the highest standard of professionalism in pharmacy. Through this Agreement, for the very first time our profession as a whole, received formal recognition and support for our professional practice – recognising that we are an essential part of the healthcare team, and importantly the respect that pharmacists deserve as clinicians in this health care system.

 

For the first time, there is shared vision between our profession and the Commonwealth Government to continue to expand the range of primary healthcare services pharmacists provide, regardless of areas of practice.

 

The Strategic Agreement gives recognition to pharmacists’ expertise and contribution to quality use of medicines and medicine safety.

 

It gives confidence to our patients, our funders and our health system. It gives our profession the framework for standards and guidelines moving forward, as we continue to navigate through practice and health landscape changes.

 

Whilst these are all positive news, as I mentioned earlier, we need to remain focused. The work is not done. Whilst there is ongoing funding for HMRs and RMMRs, and that the Aged Care On-site Pharmacist Program has now formally commenced, the work and viability of our credentialed pharmacist workforce will not be forgotten.

 

Regardless of areas of practice, I truly have never felt so positive about the opportunity for pharmacists to reach our full potential. These opportunities are driven by real needs of our patients and our health system.

 

The current Scope of Practice Review is our opportunity – it is what I would describe as a once-in-a-career lifetime opportunity to challenge the very foundation of health system administration – to achieve equity for all health professionals, including pharmacists, in terms of regulations, funding policy and workforce development. Whether it is through our submissions, in formally representing pharmacists on the Expert Advisory Committee, in attending workshops – members can be assured that PSA is making strong representation.

 

What we want to see is:

 

Removing of unnecessary red tapes, empowering pharmacists to achieve our full and top of scope in being stewards of medicines safety, to have responsibility for the outcomes of and accountability for the outcomes of medicine use, and to truly be the first port of call for primary healthcare.

 

Through national harmonisation of states and territories legislation and regulations – patients across the country should be able to access the same level of healthcare access, not just in those areas where their postcodes are in the 4000’s.

 

Direct referral to pathology – if you’re undertaking a medication review, you should be able to order and access pathology tests which are critical to making meaningful recommendations, consistent with treatment guidelines.

 

Whether you are prescribing or undertaking medication management reviews, it makes no sense you can’t send a patient for Medicare funded blood tests relevant to that service. And it certainly does not make sense that you can’t contribute clinical notes to a patient’s health record.

 

There should be consistent funding policies – We should have access to the MBS for consultation, and should be able to prescribe medicines within our scope under the PBS.

 

Same job same pay – We should get paid the same for providing a vaccination as any other immunisers.

 

Our workforce should be supported to be integrated within multidisciplinary care teams in a meaningful way – in terms of roles, recognition and remuneration.

 

We can do more, but we must also be supported and remunerated to do more. We cannot keep adding more work, we cannot keep expecting pharmacists to do more with less.

 

We need technology to be a facilitator, not a barrier.

 

We need the teams around us to take on more technical work so that we can focus on more cognitive work.

 

We need regulation that is up to date, that supports safer, more efficient care, not get in the way of it.

 

We need to spend more time using the full extent of our skills and expertise to provide patient care.

 

These are sensible and very long overdue asks. Once the report is finalised, we urge the government to start implementing the Review’s recommendations immediately.

 

Executed well, this will dramatically simplify our unnecessarily complicated health system and help all health professionals, including pharmacists, increase their capacity to provide care.

 

I want to take this opportunity to thank and acknowledge representatives from the Department of Health and Aged Care for their work, and PSA appreciates your work and we look forward to continuing our collaborative effort to achieve this aim.

 

Australians deserve a health system which functions better than it does now.

 

This afternoon, I hope you will join me in attending Minister Mark Butler’s address.

 

Today Minister Butler will officially launch our vision for the future of pharmacy practice in Australia – Pharmacists in 2030.

 

Pharmacists in 2030 leverages the real appetite for change in our health system, driven by patient needs, and importantly provides a roadmap for the next 6 years on how pharmacists’ full potential can be realised.

 

It helps government, policymakers and funders understand our value and potential.

 

While I won’t spoil its contents, I will say a huge thank you to every one of you, our members, our elected officials, PSA Team, the Australian Pharmacy Leaders Forum member organisations who are also here today, and our consumers, who contributed to this document.

 

Martin Luther King Jr once said: “The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and controversy.”

 

Pharmacists – We know it hasn’t been easy. We know practice is getting harder and more complex. We know it can be overwhelming. But, we must keep going.

 

As we continue to evolve our profession to meet healthcare needs of Australians, I see the next 5 years as critical in the development and preparation of our workforce.

 

PSA’s work will focus on building a pharmacy workforce which has the capability and capacity to meet the health needs of Australians into the future.

 

No matter what, PSA is pharmacy, and PSA is here throughout our pharmacy career, and we should never feel alone. We are here, we are all here to be your career partner to navigate the future together.

 

It is now time to welcome our Assistant Minister for Mental Health and Suicide Prevention, and Assistant Minister for Rural and Regional Health, Emma McBride, to the stage.

 

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA set to launch renewed vision for profession at national conference

31 July 2024

 

The Pharmaceutical Society of Australia (PSA) is thrilled to announce Pharmacists in 2030, its vision for the future of the pharmacy profession, will be launched this weekend at the PSA24 National Conference by Federal Health Minister, the Hon. Mark Butler MP.

 

A culmination of deep consultation with pharmacists, consumers and other health stakeholders, Pharmacists in 2030 describes how the care pharmacists provide will change over the next 6 years through the lens of both pharmacists and patients.

“The release of Pharmacists in 2023 back in 2019 was the first time that a clear vision and framework was developed to unlock the full potential of pharmacists in supporting the health and wellbeing of Australians,” said PSA National President, Associate Professor Fei Sim FPS.

“Hand-in-glove with the profession we have realised much of this vision, but there is still a long way to go.

We are now set to launch the next phase of this vision, Pharmacists in 2030, cementing the core role of pharmacists in medicines expertise and emphasising the ability of pharmacists to improve patient care.

 

“The growing expectations of our patients came through very strongly in our consumer consultation. Consumers have a very high level of trust in pharmacists, and they want us to do more.

 

“As the health needs of Australians continue to grow and become more complex, it is critical that our profession grows too. Pharmacists in 2030 is a roadmap that will guide the path forward to 2030, and beyond,” Associate Professor Sim concluded.

 

The launch of Pharmacists in 2030 will be a highlight of the PSA24 National Conference, where attendees will hear from national and global pharmacy leaders and connect with pharmacy colleagues from around Australia.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA Board leadership elected for 2024-25 term

30 July 2024

 

 

Associate Professor Fei Sim FPS has been re-elected as National President of the Pharmaceutical Society of Australia (PSA), leading an experienced Board of Directors for a third term.

 

 

Alongside Associate Professor Sim, the Board elected Professor Mark Naunton FPS and Caroline Diamantis FPS as National Vice-Presidents. The Board has also appointed Bridget Totterman MPS as Chair of the Membership, Products and Services Committee.

 

 

PSA has also announced the election of new Board director from Victoria, Dr Amy Page FPS.

 

 

PSA Chief Executive Officer Adjunct Associate Professor Steve Morris welcomed the Board election.

 

 

“PSA is led by an exceptional Board of Directors, bringing a wealth of experience from across the health sector,” he said.

 

 

“Under the continued leadership of Associate Professor Fei, our Board continues to deliver nation-leading support for pharmacists while driving a strong vision for the future Australian pharmacy practice. I’m looking forward to continuing this work alongside these outstanding leaders.”

 

 

Associate Professor Fei Sim, who was first elected as President in June 2022, said it was an honour to be re‑elected.

 

 

“Alongside Board of experienced, passionate directors and our CEO Steve Morris, we are excited to continue championing the roles of pharmacists wherever medicines are and leading PSA through the evolving pharmacy landscape.

 

 

“As the demand for pharmacist expertise grows, particularly in primary care, PSA’s role is more important than ever. The Board is focused on furthering our career-long support for pharmacists, particularly in delivering nation-leading education and training, bolstering practice support, and promoting a sustainable, fulfilling future for all pharmacists.

 

 

“On behalf of PSA, I’d like to thank outgoing Vice-President Benjamin Marchant for his service to the Board and the profession. I look forward to continuing to work with Ben as he continues his role representing pharmacists on the Victorian branch committee,” she concluded.

 

 

The 2024-25 Board of Directors includes:

  • Associate Professor Fei Sim FPS, National President & Chair (Western Australia)
  • Professor Mark Naunton MPS, National Vice-President (ACT) – Chair of Finance, Audit & Risk Management Committee
  • Ms Caroline Diamantis FPS, National Vice-President (New South Wales) – Chair of Policy & Advocacy Committee
  • Ms Bridget Totterman MPS, Board Director (Queensland) – Chair of Membership, Products & Services Committee
  • Mr Tony Evans, Board-appointed independent Director (Western Australia) – Chair of Governance, People & Culture Committee
  • A/Prof Shane Jackson FPS, Board Director (Tasmania) – Agreements Lead
  • Dr Helen Benson FPS, Board Director (New South Wales)
  • Dr Amanda Cross FPS, Board Director (Victoria)
  • Dr Amy Page FPS, Board Director (Victoria)
  • Dr Natalie Soulsby FPS, Board Director (South Australia)
  • Ms Ayomide Ogundipe, Board-appointed Early Career Pharmacist Director (Western Australia)
  • Ms Sara Pantzer, Board-appointed independent Director (New South Wales)

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Scope of Practice on the agenda for Northern Territory Election

25 July 2024

 

Territorians may soon have greater access to health services through community pharmacists as both major parties look to improve access to care ahead of the Northern Territory’s August election.

 

Opposition Leader Lia Finocchiaro this week announced the Northern Territory Community Pharmacy Scope of Practice program, allowing pharmacists to treat ‘up to 21 conditions’ if the Country Liberal Party (CLP) is elected to government in August.

 

Meanwhile the Northern Territory Government launched a consultation earlier this month, seeking community feedback on what expanded community pharmacy services could look like in the Territory.

 

PSA Northern Territory and South Australia Vice-President Colleen Niland welcomed the focus on pharmacy services.

 

“The Northern Territory is home to 270 pharmacists who can and should be empowered to contribute more to the health of Territorians. PSA strongly supports scope of practice changes and better utilisation of pharmacists’ skills and expertise, including through programs that empower pharmacists to treat common health concerns.

 

“PSA welcomes the CLP’s commitment to expand pharmacist services if they are elected in August. We want to see pharmacists empowered to do more for their patients and our Territorians, and look forward to the release of NT Labor’s health policy in due course.

 

“Acknowledging the vital role general practitioners hold, greater access to health services through community pharmacists will free up GPs, especially during the tourist surge when there is increased demand.

 

“Almost all Australian jurisdictions have now implemented trials or programs allowing pharmacists to treat urinary tract infections (UTIs), an initiative that’s been welcomed by patients, and it’s time for the Northern Territory to catch up and support our Territorians.

 

“Allowing pharmacists to treat uncomplicated UTIs, deliver more vaccines, or provide antivirals for COVID-19 and influenza would mean more time available for GPs to spend on more complex health needs.

“As pharmacists we want to do more for our patients, and our patients want us to be able to do more,” Ms Niland concluded.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Australians urged to speak to pharmacists as health misinformation grows

24 July 2024

 

The Pharmaceutical Society of Australia (PSA) is today encouraging Australians to leave behind the advice of unverified websites and online influencers and instead visit their local pharmacist for accurate health information as it marks International Self-Care Day.

 

With the increasing availability of unverified and often inappropriate ‘health hacks’ online, PSA recognises the increasingly important role of pharmacists in tackling online misinformation while empowering Australians to be active agents in their own healthcare.

 

As a member Australia Self-Care Alliance PSA promotes the adoption of self-care through pharmacists, maintaining a suite of over 100 Self-Care Fact Cards to provide evidence-based health information to consumers.

 

PSA National President Associate Professor Fei Sim FPS said that misinformation can risk the health and wellbeing of Australians.

 

“Appropriate self-care does not replace the care provided by professionals, but enhances it,” A/Prof Sim said.

 

“Self-care is important as part of keeping yourself and your family healthy, but more and more often we’re seeing consumers getting health information from social media, which is often not based in evidence, and in some cases can be very dangerous.

 

“Pharmacists are registered health professionals who give evidence-based health advice to Australians. Instead of trusting social media influencers and the internet, I strongly encourage patients to speak with their local pharmacist about their health concerns where we can give you accurate health information or refer you on to the right healthcare provider.

 

“Today’s International Self-Care Day is a great reminder not only to look after your health and wellbeing, but also of the importance of following accurate health information,” A/Prof Sim concluded.

 

More information on self-care is available via the World Health Organization.

Pharmacists are encouraged to read the International Pharmaceutical Federation (FIP) resource Empowering self-care: A handbook for pharmacists

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA launches hormonal contraceptive prescribing training for Queensland pharmacists

17 July 2024

 

Queensland pharmacists participating in the Queensland Community Pharmacy Hormonal Contraception Pilot can now enrol in the Sexual and Reproductive Health Contraceptive Service – Queensland training program launched by the Pharmaceutical Society of Australia (PSA) today.

 

Completion of the course allows pharmacists to prescribe hormonal contraception for female patients aged 16 years and older under the Pilot.

 

PSA’s training program features cutting-edge AI technology, allowing pharmacists to engage with a virtual patient in a simulated consultation to build confidence and competence in prescribing.

 

PSA General Manager – Education and Training Kerri Barwick encouraged pharmacists to undertake training to deliver contraception prescribing services.

 

“This new training initiative is an important step forward in supporting the role of pharmacists in reproductive health,” Ms Barwick said.

 

“Pharmacists prescribing hormonal contraception will mean more accessible care for Queensland women, putting patient care first and ensuring safe and effective contraception options are available when and where they’re needed.

 

“PSA’s training program is one of the first to utilise artificial intelligence, giving pharmacists the opportunity to test their skills in a simulated clinical environment. We’re excited to continue to innovate how we deliver nation-leading education to Australian pharmacists.

 

“PSA continues to work closely with the Queensland Government to deliver training and education to pharmacists as part of the Queensland community pharmacy pilots. On behalf of PSA, we again commend the Queensland Government for implementing the most progressive scope of practice pilot in the country.”

 

The Sexual and Reproductive Health Contraceptive Service – Queensland is open for enrolments now.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists mark NAIDOC Week

8 July 2024

 

This week, the Pharmaceutical Society of Australia (PSA) acknowledges NAIDOC Week from 7 to 14 July 2024, celebrating and recognising the history, culture and achievements of Aboriginal and Torres Strait Islander peoples.

 

The theme of NAIDOC Week 2024 is Keep the Fire Burning! Blak, Loud and Proud.

 

In the spirit of continued learning, PSA continues to encourage all pharmacists practising in Australia to undertake the Deadly Pharmacists Foundation Training Program developed in co-design with the National Aboriginal Community Controlled Health Organisation (NACCHO), growing the cultural knowledge and understanding that underpins quality health care.

 

PSA National President Associate Professor Fei Sim FPS reaffirmed the role of pharmacists in recognising and implementing culturally safe care.

 

“All healthcare professionals have a responsibility to provide health care that is culturally responsive for Aboriginal and Torres Strait Islander Australians,” Associate Professor Sim said.

 

“This NAIDOC Week, PSA once again recognises the important role pharmacists can play in closing the gap and improving health outcomes for First Nations people.”

 

“PSA’s longstanding commitment to culturally safe health care continues to grow, working with Aboriginal and Torres Strait Islander organisations to promote a truly patient-centred model of care that recognises and works with – not against – our patients’ cultures.

 

“We continue to advocate for permanent funding for the integration of pharmacists into Aboriginal and Torres Strait Islander primary health services following a positive MSAC recommendation in 2023. This model of care has been proven to make a significant improvement to the health outcomes of Aboriginal and Torres Strait Islander peoples.

 

The Deadly Pharmacists Foundation Training Program is free and available to all Australian pharmacists. PSA encourages all pharmacists interacting with patients to make a commitment to undertake the training this NAIDOC Week, gaining a better understanding of the health needs of First Nations people.

Additionally, pharmacists who are looking to gain the new MMR credential can upload their certificate of completion of the Deadly Pharmacists Foundation Training program as evidence of APC Performance Outcome 1.1, demonstrating their learning in the area of promoting, maintaining and advocating for cultural safety, respect and responsiveness in relation to Aboriginal and Torres Strait Islander peoples.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA welcomes new NAPSA Board

8 July 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes the election of Sebastian Harper (Griffith University) as President of the National Australian Pharmacy Students’​ Association (NAPSA) over the weekend.

 

PSA also recognises and congratulates the incoming NAPSA executive elected alongside Mr Harper to serve for the 2024/25 term.

 

PSA National President Associate Professor Fei Sim FPS congratulated the incoming Board.

 

“Congratulations to Sebastian Harper and his team on their election as the next leaders of NAPSA,” Associate Professor Sim said.

 

“Sebastian has been a fantastic leader as NAPSA Treasurer, and we look forward to continuing to work with him in his new role as President.

 

“PSA works closely with NAPSA to ensure that students are supported, and their voices heard on issues affecting their futures.

 

“We are proud to support NAPSA through our joint Memorandum of Understanding, continuing to strengthen the partnership between PSA and pharmacy students.

 

“I also wish to congratulate outgoing President Bano Serhan for her commitment and service to the NAPSA Board and pharmacy students over the past year. On behalf of PSA, we wish Bano the best for the rest of her studies and look forward to continuing to support her throughout her career as a pharmacist.”

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacy Student of the Year finalists head to PSA24

5 July 2024

 

 

The Pharmaceutical Society of Australia (PSA) has today announced the finalists for its annual Pharmacy Student of the Year competition who will compete for the top prize at PSA’s national conference PSA24 in August.

 

The final will test pharmacy students with a real-life clinical situation, where a patient will present with symptoms or a specific medicine or product request. Students are then required to use their clinical knowledge and communication skills to identify the most appropriate management, tailoring their response to provide the patient-centred advice.

 

A judging panel will assess all state finalists before selecting the national winner to be announced at PSA24’s Gala Dinner.

 

The 2024 PSA Viatris Pharmacy Student of the Year finalists are:

  • Blake Fraser, University of Technology Sydney (NSW finalist)
  • Emily Schrek, La Trobe University (Victorian finalist)
  • Bridget Cleary, University of Western Australia (WA finalist)
  • Tobey Adubasim, University of Tasmania (Tasmanian finalist)
  • Hayden Scott, University of Canberra (ACT finalist)
  • Shylee-Jade Hadar-Pagliari, James Cook University (Queensland finalist)
  • Callum Gunn, University of South Australia (SA finalist)
  • Lauren Murray, Charles Darwin University (NT finalist)
  • McKinley Nolan, University of Tasmania (NAPSA Wildcard finalist)

 

PSA National President Associate Professor Fei Sim FPS congratulated the PSOTY competition finalists.

 

“The Pharmacy Student of the Year competition showcases the talents of the next generation of pharmacists, giving them the opportunity to develop and grow their skills,” Associate Professor Sim said.

 

“It’s exciting to see such enthusiastic students entering our profession and dedicating their futures to improving the health and wellbeing of our communities.

 

“Award sponsor Viatris and PSA are proud to sponsor the finalists to attend the PSA24 conference where they will compete in the national finals.

 

“Congratulations to all the students who’ve participated in the competition this year for their dedication and commitment to pharmacy. Regardless of the outcome, you are already winners and should feel very proud for putting yourselves out of your comfort zone, for stepping up and taking on the challenge. This is exactly the ethos of our profession.”

 

PSA extends thanks to the PSOTY award sponsor, Viatris, for their ongoing support and wishes all finalists the best of luck at the national final.

 

Find out more about the PSA Pharmacy Student of the Year competition by visiting www.psa.org.au/psoty 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Experienced pharmacy leader elected as PSA Tasmania President

3 July 2024

 

The Pharmaceutical Society of Australia (PSA) is proud to announce the election of experienced pharmacy leader Mark Kirschbaum FPS to lead the Tasmanian branch.

 

Mr Kirschbaum is the Pharmacy Board of Australia’s practitioner member from Tasmania, a locum community pharmacist and academic at the University of Tasmania in Launceston.

 

Mr Kirschbaum is experienced in regulation, policy and advocacy, and has worked collaboratively with PSA over many years to improve patient access to care and quality use of medicines. Recently, Mr Kirschbaum has been involved in the redevelopment of Professional Practice Standards and the Tasmanian Government’s Scope of Practice Review for Pharmacists.

 

Outgoing Tasmanian Branch President David Peachey will continue to serve as Vice-President, alongside Joanne Gross MPS, with Dr Shane Jackson FPS continuing as National Board Director.

 

Mr Kirschbaum thanked outgoing President David Peachey MPS for his service to the profession and the Tasmanian Branch.

 

“I sincerely thank David Peachey for his leadership as President of our branch since 2021. I look forward to continuing to work with Vice-Presidents Dave and Joanne, and the Branch Committee to represent and support Tasmanian pharmacists.”

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au